Valneva (VALN) News Today $8.64 -0.20 (-2.21%) As of 02:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VALN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period VALNEVA Declaration of shares and voting rights: August 31, 20254 hours ago | finance.yahoo.comVALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the FirmSeptember 4 at 5:33 PM | globenewswire.comValneva (NASDAQ:VALN) Shares Gap Down - Here's What HappenedSeptember 4 at 12:59 PM | marketbeat.comValneva Reports Positive Phase 2 Results for Lyme Disease VaccineSeptember 3 at 12:54 PM | msn.comValneva Shares Rise on Lyme Disease Vaccine Study DataSeptember 3 at 7:54 AM | marketwatch.comValneva Reports Further Positive Phase 2 Safety and Immunogenicity Results for Lyme Disease Vaccine CandidateSeptember 3 at 2:00 AM | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Valneva (NASDAQ:VALN)August 27, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - Time to Sell?August 27, 2025 | marketbeat.comValneva Outlook: Safety Blow To Ixchiq And Valuation ConcernsAugust 26, 2025 | seekingalpha.comValneva Stock Tumbles 19% After FDA Suspension Of Ixchiq License In US, Wall Street Divided On The ImpactAugust 26, 2025 | msn.comValneva stock tumbles as FDA suspends license for IXCHIQ vaccineAugust 25, 2025 | za.investing.comValneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.August 25, 2025 | marketwatch.comSafety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In USAugust 25, 2025 | benzinga.comValneva shares tumble after suspension of US chikungunya vaccine licenceAugust 25, 2025 | msn.comKeurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On MondayAugust 25, 2025 | benzinga.comJohnson Fistel Investigates Valneva Following FDA SuspensionAugust 25, 2025 | globenewswire.comValneva: U.S. Suspends License For Chikungunya Vaccine IXCHIQ Following New Safety ConcernsAugust 25, 2025 | nasdaq.comValneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.August 25, 2025 | markets.businessinsider.comFDA suspends Valneva's chikungunya vaccine license in the U.SAugust 25, 2025 | msn.comValneva shares tumble after suspension of U.S. chikungunya vaccine licenceAugust 25, 2025 | msn.comFDA suspends Valneva's chikungunya vaccine license in the U.S.August 25, 2025 | reuters.comValneva Announces FDA's Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.August 25, 2025 | globenewswire.comValneva suspended from marketing chikungunya shot in U.S. over safety concernsAugust 23, 2025 | msn.comQ3 Earnings Estimate for Valneva Issued By HC WainwrightAugust 23, 2025 | marketbeat.comValneva SE (ADR) trading halted, news pendingAugust 22, 2025 | msn.comValneva (NASDAQ:VALN) Hits New 52-Week High - Should You Buy?August 22, 2025 | marketbeat.comValneva (NASDAQ:VALN) Given Buy Rating at HC WainwrightAugust 21, 2025 | marketbeat.comValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - What's Next?August 20, 2025 | marketbeat.comValneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and OlderAugust 19, 2025 | finance.yahoo.comValneva’s Chikungunya Vaccine IXCHIQ® Gains Health Canada ApprovalAugust 19, 2025 | msn.comValneva assumed with a Buy at H.C. WainwrightAugust 19, 2025 | msn.comValneva SE Sponsored ADR (NASDAQ:VALN) Short Interest UpdateAugust 19, 2025 | marketbeat.comValneva's Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and OlderAugust 18, 2025 | globenewswire.comValneva (NASDAQ:VALN) Trading 14.3% Higher Following Strong EarningsAugust 15, 2025 | marketbeat.comValneva (NASDAQ:VALN) Sets New 1-Year High - Time to Buy?August 15, 2025 | marketbeat.comA Vaccine for a Mosquito-Borne Disease Fuels Valneva Stock RallyAugust 15, 2025 | bloomberg.comValneva (NASDAQ:VALN) Shares Gap Up Following Better-Than-Expected EarningsAugust 13, 2025 | marketbeat.comValneva (NASDAQ:VALN) Announces Quarterly Earnings Results, Beats Estimates By $0.11 EPSAugust 13, 2025 | marketbeat.comValneva (NASDAQ:VALN) Sees Strong Trading Volume - Time to Buy?August 12, 2025 | marketbeat.comValneva SE 2025 Q2 - Results - Earnings Call PresentationAugust 12, 2025 | seekingalpha.comValneva Shares Gain After Results, OutlookAugust 12, 2025 | marketwatch.comValneva (NASDAQ:VALN) Trading Down 6.7% - Here's What HappenedAugust 12, 2025 | marketbeat.comValneva Reports Half Year 2025 Financial Results and Provides Corporate UpdatesAugust 12, 2025 | globenewswire.comValneva SE (VALN) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 11, 2025 | finance.yahoo.comValneva (NASDAQ:VALN) Hits New 12-Month High - Here's WhyAugust 9, 2025 | marketbeat.comFDA removes Ixchiq partial pause but tightens vaccine’s useAugust 8, 2025 | finance.yahoo.comFDA lifts pause on Valneva's chikungunya vaccine in elderlyAugust 8, 2025 | msn.comFDA lifts pause on Valneva’s chikungunya shot, but adds new limitsAugust 8, 2025 | yahoo.comValneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing InformationAugust 7, 2025 | globenewswire.comValneva (VALN) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.320.71▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼75▲VALN Articles Average Week Get the Latest News and Ratings for VALN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Valneva and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LNTH News ACLX News AKRO News ZLAB News MIRM News MLTX News PTGX News APLS News MENS News MTSR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VALN Stock Alerts